نتایج جستجو برای: ضریب تغییرات cov

تعداد نتایج: 158079  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Xian-Chun Tang Sudhakar S Agnihothram Yongjun Jiao Jeremy Stanhope Rachel L Graham Eric C Peterson Yuval Avnir Aimee St Clair Tallarico Jared Sheehan Quan Zhu Ralph S Baric Wayne A Marasco

The newly emerging Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes a Severe Acute Respiratory Syndrome-like disease with ∼43% mortality. Given the recent detection of virus in dromedary camels, zoonotic transfer of MERS-CoV to humans is suspected. In addition, little is known about the role of human neutralizing Ab (nAb) pressure as a driving force in MERS-CoV adaptive evolution....

2017
P. Hartnady D. Martin B. Muhire P. Roumagnac

ing infections in humans is genetically indistinguishable from the virus found in Arabian camels (dromedaries) in the Middle East. Although no primary human case of MERS was reported outside the Arabian Peninsula, camel populations in Africa are known to have high prevalence of antibodies against MERS-CoV. We carried out surveillance for MERS-CoV in dromedaries in Africa and Central Asia. By ME...

2014
Isabella Eckerle Victor M. Corman Marcel A. Müller Matthias Lenk Rainer G. Ulrich Christian Drosten

Replicative capacity of Middle East respiratory syndrome coronavirus (MERS-CoV) was assessed in cell lines derived from livestock and peridomestic small mammals on the Arabian Peninsula. Only cell lines originating from goats and camels showed efficient replication of MERS-CoV. These results provide direction in the search for the intermediate host of MERS-CoV.

2014
V. Stalin Raj Elmoubasher A.B.A. Farag Chantal B.E.M. Reusken Mart M. Lamers Suzan D. Pas Jolanda Voermans Saskia L. Smits Albert D.M.E. Osterhaus Naema Al-Mawlawi Hamad E. Al-Romaihi Mohd M. AlHajri Ahmed M. El-Sayed Khaled A. Mohran Hazem Ghobashy Farhoud Alhajri Mohamed Al-Thani Salih A. Al-Marri Mamdouh M. El-Maghraby Marion P.G. Koopmans Bart L. Haagmans

We obtained the full genome of Middle East respiratory syndrome coronavirus (MERS-CoV) from a camel in Qatar. This virus is highly similar to the human England/Qatar 1 virus isolated in 2012. The MERS-CoV from the camel efficiently replicated in human cells, providing further evidence for the zoonotic potential of MERS-CoV from camels.

2017
Júlia Vergara-Alert Judith M.A. van den Brand W. Widagdo Marta Muñoz Stalin Raj Debby Schipper David Solanes Ivan Cordón Albert Bensaid Bart L. Haagmans Joaquim Segalés

Middle East respiratory syndrome (MERS) cases continue to be reported, predominantly in Saudi Arabia and occasionally other countries. Although dromedaries are the main reservoir, other animal species might be susceptible to MERS coronavirus (MERS-CoV) infection and potentially serve as reservoirs. To determine whether other animals are potential reservoirs, we inoculated MERS-CoV into llamas, ...

Journal: :Science 2016
Jamal S M Sabir Tommy T-Y Lam Mohamed M M Ahmed Lifeng Li Yongyi Shen Salah E M Abo-Aba Muhammd I Qureshi Mohamed Abu-Zeid Yu Zhang Mohammad A Khiyami Njud S Alharbi Nahid H Hajrah Meshaal J Sabir Mohammed H Z Mutwakil Saleh A Kabli Faten A S Alsulaimany Abdullah Y Obaid Boping Zhou David K Smith Edward C Holmes Huachen Zhu Yi Guan

Outbreaks of Middle East respiratory syndrome (MERS) raise questions about the prevalence and evolution of the MERS coronavirus (CoV) in its animal reservoir. Our surveillance in Saudi Arabia in 2014 and 2015 showed that viruses of the MERS-CoV species and a human CoV 229E-related lineage co-circulated at high prevalence, with frequent co-infections in the upper respiratory tract of dromedary c...

2017
Wei Hao Justyna Aleksandra Wojdyla Rong Zhao Ruiyun Han Rajat Das Ivan Zlatev Muthiah Manoharan Meitian Wang Sheng Cui

Middle East respiratory syndrome coronavirus (MERS-CoV) remains a threat to public health worldwide; however, effective vaccine or drug against CoVs remains unavailable. CoV helicase is one of the three evolutionary most conserved proteins in nidoviruses, thus making it an important target for drug development. We report here the first structure of full-length coronavirus helicase, MERS-CoV nsp...

2003
Jianfei Hu Jing Wang Jing Xu Wei Li Yujun Han Yan Li Jia Ji Jia Ye Zhao Xu Zizhang Zhang Wei Wei Songgang Li Jun Wang Jian Wang Jun Yu Huanming Yang

Knowledge of the evolution of pathogens is of great medical and biological significance to the prevention, diagnosis, and therapy of infectious diseases. In order to understand the origin and evolution of the SARS-CoV (severe acute respiratory syndrome-associated coronavirus), we collected complete genome sequences of all viruses available in GenBank, and made comparative analyses with the SARS...

Journal: :The Journal of general virology 2004
Tobias Hertzig Elke Scandella Barbara Schelle John Ziebuhr Stuart G Siddell Burkhard Ludewig Volker Thiel

A previously unknown coronavirus (CoV) is the aetiological agent causing severe acute respiratory syndrome (SARS), for which an effective antiviral treatment is urgently needed. To enable the rapid and biosafe identification of coronavirus replicase inhibitors, we have generated a non-cytopathic, selectable replicon RNA (based on human CoV 229E) that can be stably maintained in eukaryotic cells...

Journal: :Acta biochimica et biophysica Sinica 2004
Ping Zhao Jin-Shan Ke Zhao-Lin Qin Hao Ren Lan-Juan Zhao Jian-Guo Yu Jun Gao Shi-Ying Zhu Zhong-Tian Qi

The spike (S) protein, a main surface antigen of SARS-coronavirus (SARS-CoV), is one of the most important antigen candidates for vaccine design. In the present study, three fragments of the truncated S protein were expressed in E.coli, and analyzed with pooled sera of convalescence phase of SARS patients. The full length S gene DNA vaccine was constructed and used to immunize BALB/c mice. The ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید